FUJIFILM SONOSITE INC., INNOVATOR OF POINT-OF-CARE ULTRASOUND, CELEBRATES 20 YEARS OF IMPROVING PATIENT OUTCOMES
From battlefield to bedside, these rugged and reliable solutions have ushered in a new era of helping clinicians bring ultrasound to any patient, anywhere, anytime.
BOTHELL, Wash., July 20, 2018 – FUJIFILM SonoSite Inc., specialists in developing cutting-edge, portable and point-of-care ultrasound solutions, today announced that the company is celebrating the inception of FUJIFILM SonoSite Inc. and point-of-care ultrasound with the 20th anniversary of the SonoSite 180 launch. As the first point-of-care ultrasound machine, the SonoSite 180 developed by FUJIFILM SonoSite in 1998 signified a major step forward in ultrasound technology and was the catalyst to enable clinicians to bring ultrasound to any patient, in any environment for the first time ever. The introduction of this new technology broke the convention within ultrasound, by ensuring that point-of-care ultrasound is durable, mobile and reliable– resulting in care for those in need in the most remote areas of the world.
“For the past twenty years clinicians have turned to FUJIFILM SonoSite Inc. as a reliable and trusted partner to deliver innovative point-of-care ultrasound systems with extreme portability, image optimization and intuitive controls,” said Diku Mandavia, M.D., senior vice president and chief medical officer of FUJIFILM SonoSite Inc. and FUJIFILM Medical Systems U.S.A., Inc. “Since the introduction of point-of-care ultrasound with the SonoSite 180, clinicians can utilize ultrasound anywhere and anytime to provide clinical answers that are critical in the decision making process and can ultimately save lives.”
FUJIFILM SonoSite Inc. evolved from its roots with the United States Department of Defense to build the world’s first ultrasound for the battlefield, to now helping clinicians everywhere in a range of applications such as pediatrics, surgery, veterinary, physical therapy and even helping to combat the opioid over-prescription epidemic with ultrasound guided nerve blocks. Today, the company is regarded by clinicians all over the world as the most adopted and considered point-of-care ultrasound brand.
As point-of-care ultrasound continues to gain traction around the globe to help improve patient outcomes, FUJIFILM SonoSite Inc. will continue to be a reliable technology partner to clinicians, by continuing technological innovation and offering educational opportunities.
To learn more about FUJIFILM SonoSite Inc. and 20 years of point-of-care ultrasound please visit: https://www.sonosite.com/about/sonosites-history
FUJIFILM SonoSite, Inc., is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra high-frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by 26 subsidiaries and a global distribution network in over 100 countries. SonoSite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, go to: www.sonosite.com.
FUJIFILM Holdings Corporation in Tokyo, Japan, brings innovative solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies derived from photographic film. Its proprietary core technologies contribute to the fields of healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2018, the company had global revenues of $23.0 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.